Featured Editorial
-
Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
9/22/2026
This third installment of our Root Causes video series examines how administrative complexity can consume resources that might otherwise improve clinical trial execution.
-
The Silent Stockout: No One Owns The Data That Would Have Caught It
9/22/2026
Five systems can each be correct and still leave a patient without medicine. The missing piece is ownership of the data connecting supply, sites, protocols, and patients.
-
Token Costs Will Decide Clinical Supply AI
9/21/2026
AI may make clinical supply forecasting faster, but cheaper tokens can drive higher costs. See how to measure AI at scale before a pilot becomes an expensive surprise.
-
What Is "Demand" When There Are No Sales?
9/18/2026
Clinical-stage companies have no sales history, but they still have demand. Here’s how to uncover the four streams driving supply planning before material gets tight.
-
The Reliance Trap: When Regulatory Strategy Becomes A Clinical Supply Problem
9/17/2026
The wrong regulatory filing sequence can close faster pathways, delay importation, and consume shelf life. Here’s how regulatory strategy can reshape clinical supply.
-
Clinical Trial Supply Chains Are Entering The Era Of Predictive Risk Management
9/16/2026
Clinical supply teams can do more than react to disruption. Predictive risk management uses early signals, connected data and analytics to anticipate supply problems.
-
Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
9/15/2026
This second installment of our Root Causes video series explores how protocol assumptions can create downstream operational and clinical supply challenges.
-
CSM Feasibility Begins With Research Strategy And Study Design
9/15/2026
Study design decisions can create costly clinical supply problems months later. Early CSM review can expose hidden requirements before they become delays, waste, and rework.
-
Clinical Supply Systems Need IT General Controls
9/14/2026
Validating a clinical trial system does not prove it stays trustworthy. IT general controls can protect data, supply decisions and patient safety long after go-live.
-
AI-Generated Data, Patent Protection, And The Implications For Clinical Supply
9/11/2026
AI-generated data could change how clinical supply teams forecast demand, plan manufacturing, and manage inventory, but knowing when to trust those signals is the real challenge.